期刊文献+

复方丹参注射液合血活素治疗高血压脑出血疗效观察 被引量:1

Observation on therapeutic effect of Compound Danshen Injection and Deproteinized Calf-blood Extractives on patients with hypertensive cerebral hemorrhage
下载PDF
导出
摘要 目的 :评价复方丹参注射液 (丹参 )在急性高血压脑出血中的治疗作用。方法 :将受治的 6 3例高血压脑出血患者(年龄 5 6~ 78岁 ,平均 6 1.9岁 )。在常规治疗的基础上 ,随机分为 3组 :复方丹参加血活素组 ,立止血加血活素组 ,单用血活素组。观察各组临床疗效、血肿吸收率、ADP诱导的血小板聚集率 (ADP pag)和凝血酶原时间 (PT)等指标。 结果 :采用格拉斯哥预后评分 (GOS)方法 ,复方丹参组中恢复良好和中等残疾 (GR +MD)者占 83.34% ,立加血组为 4 7.6 1% ,单用血活素组为 6 1.11% ,经Ridit检验 ,有显著性差异 (P <0 .0 5 ) ,复方丹参组疗效最佳 ,其血肿吸收率与其他两组比较 ,经Ridit检验 ,有显著性差异 (P <0 .0 5 )。复方丹参组不影响血小板凝血功能 ,ADP pag、PT值在正常范围。 结论 :复方丹参注射液是一种治疗急性高血压性脑出血安全有效药物 ,值得临床推广应用。 Objective: To assess the effect of Compound Danshen(CD) Injection (Radix Salviae Militiorrhizae) in the treatment of hypertensive cerebral hemorrhage (HCH). Methods : Sixty-three cases (aged 56~78, 61.9 years on average) with HCH were randomly divided into three groups: (CD+Deproteinized Calf-blood Extractives (DCE) group and Reptilase+DCE group as the treated groups, DCE group as the control group) to observe the outcome of the clinical treatment, hematoma absorbability and changes of ADP-platelet agglutination rate (Pag) and prothrombin time (PT). Results : The rate of the good result (GR) and moderate disability (MD) in CD group was 83.34% with the method of Glasgow outcome score (GOS), others were 47.61% and 61.11% ,respectively. they have significant difference, P <0.05. Among them, CD group had best result. Compared the rate of hematoma absorbability of CD group with that of Reptilase, DCE groups, the difference was significant, P < 0.05 . It did not affect the platelet coagulative function in CD group. Conclusion : CD Injection could effectively improve the condition of patients with HCH, and with little side effect, It is worthwhile to be used in the clinical practice.
出处 《中成药》 CAS CSCD 北大核心 2003年第8期634-636,共3页 Chinese Traditional Patent Medicine
关键词 高血压脑出血 复方丹参注射液 疗效观察 中医药治疗 hypertensive cerebral hemorrhage Compound Danshen Injection observation of effect
  • 相关文献

参考文献8

二级参考文献20

共引文献63

同被引文献42

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部